Predictors of drug survival for tumour necrosis factor-α and interleukin 12/23 antagonists in psoriasis
Br J Dermatol
.
2016 Aug;175(2):247-8.
doi: 10.1111/bjd.14612.
Author
A Egeberg
1
Affiliation
1
Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, 2900, Hellerup, Denmark. alexander.egeberg@gmail.com.
PMID:
27535601
DOI:
10.1111/bjd.14612
No abstract available
Publication types
Comment
MeSH terms
Humans
Interleukin-12
Interleukin-23*
Interleukin-6
Psoriasis
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
Interleukin-23
Interleukin-6
Tumor Necrosis Factor-alpha
Interleukin-12